These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 416312)

  • 1. Practical aspects in the provision of plasma for the preparation of anti-Rh immunoglobin.
    Taverner JM; Tovey LA
    Med Lab Sci; 1978 Jan; 35(1):19-30. PubMed ID: 416312
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary anti-D immunization by Del red blood cells.
    Yasuda H; Ohto H; Sakuma S; Ishikawa Y
    Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frozen recovered red cell boosting of female donors for anti-D-production.
    Gabra GS; Black M; Mitchell R
    Vox Sang; 1986; 50(3):137-40. PubMed ID: 3087060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-D alloimmunization by weak D type 1 red blood cells with a very low antigen density.
    Mota M; Fonseca NL; Rodrigues A; Kutner JM; Castilho L
    Vox Sang; 2005 Feb; 88(2):130-5. PubMed ID: 15720611
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence of Rh anti-E and anti-c production among Japanese after blood transfusion.
    Komatsu F
    Bull Tokyo Med Dent Univ; 1988 Sep; 35(3):75-9. PubMed ID: 3148374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Obtaining blood group test serums and initial plasma for the preparation of anti D-immunologlobulin for prevention of hemolytic disease of newborn by artificial immunization].
    Pilgrim G; Wicht U
    Z Gesamte Inn Med; 1971 Jan; 26(1):26-30. PubMed ID: 4997869
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood transfusion and blood bank management in a tropical country.
    David-West AS
    Clin Haematol; 1981 Oct; 10(3):1013-28. PubMed ID: 6796320
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of remote observations of "immune" donors with Rh-negative blood subjected to active immunization and re-immunization with Rh-positive blood].
    Nersisian VM; Shcherbakova LN; Babaian BG; Osipova EN; Avakian AA
    Probl Gematol Pereliv Krovi; 1975 Jul; 20(7):50-1. PubMed ID: 812080
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of anti-Rh-immunoprophylaxis in the Berlin-Friedrichshain hospital].
    Rössner P; Moeller HG; Krüger D
    Zentralbl Gynakol; 1976; 98(16):1005-16. PubMed ID: 823738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year experience with high titer anti-D plasma for the prevention of Rh isoimmunization.
    Hamilton EG
    Obstet Gynecol; 1972 Nov; 40(5):692-6. PubMed ID: 4628388
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of planned immunization of Rh-negative subjects with Rh-positive blood].
    Kuśnierz G; Maślanka K
    Acta Haematol Pol; 1976; 7(1):49-56. PubMed ID: 814766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of 2-years experiences with crossmatching in the Institute of Hematology].
    Frankowska K; Górska B; Kacperska E; Maczyńska-Rusiniak B; Seyfried H
    Pol Tyg Lek; 1969 Jun; 24(22):838-41. PubMed ID: 4979419
    [No Abstract]   [Full Text] [Related]  

  • 13. [Practical realization of the prevention of Rh immunisation].
    Pinon F; Cregut R; Poulain M; Huchet J
    Gynecol Obstet (Paris); 1969; 68(5):469-78. PubMed ID: 4189000
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fetomaternal transfusion, Rhesus immunization and prevention. II. Rhesus immunization and prevention].
    Helderweirt G
    Verh K Acad Geneeskd Belg; 1976; 38(3-4):79-134. PubMed ID: 826036
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of plasmapheresis on the blood cells of RH(-) donors immunized with RH(+) blood.
    Raicheva D; Ivanova L; Dobreva A
    C R Acad Bulg Sci; 1976; 29(10):1547-50. PubMed ID: 828104
    [No Abstract]   [Full Text] [Related]  

  • 16. [Polyagglutination. Serologic diagnosis and clinical significance demonstrated by means of Tn-activation].
    Dörner R; Sachs V
    MMW Munch Med Wochenschr; 1982 May; 124(19):483-4. PubMed ID: 6810115
    [No Abstract]   [Full Text] [Related]  

  • 17. [GEK-NEU: triply washed erythrocytes from O Rh-negative and CMV-seronegative donors withdrawn less than 4 days before transfusion into newborn infants at risk].
    Diekamp U; Miceli C; Gylys L; Caccese M
    Beitr Infusionther Klin Ernahr; 1987; 18():133-9. PubMed ID: 2830875
    [No Abstract]   [Full Text] [Related]  

  • 18. The performance of an anti D immunoprophylaxis scheme.
    Kinnock S; Liley AW
    N Z Med J; 1974 Oct; 80(526):337-43. PubMed ID: 4216865
    [No Abstract]   [Full Text] [Related]  

  • 19. Component therapy.
    Schmidt PJ
    Int Anesthesiol Clin; 1982; 20(4):23-43. PubMed ID: 6816740
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunohematologic blood testing of pregnant women and of women in childbed conducted in the Blood Transfusion Institute of S.R. Croatia (author's transl)].
    Latal-Duancić M
    Lijec Vjesn; 1981; 103(2-3):112-4. PubMed ID: 6796794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.